Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD
1Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, China.
Abstract:
Trimethylamine-N-oxide (TMAO) is a molecular metabolite derived from the gut flora, which has recently emerged as a candidate risk factor for metabolic dysfunction-associated fatty liver disease (MAFLD). TMAO is mainly derived from gut, where the gut microbiota converts TMA precursors into TMA, which is absorbed into the bloodstream through the intestinal mucosa, and then transformed into TMAO by hepatic flavin monooxygenases (FMOs) in the liver. High-nutrient diets rich in TMA precursors, such as red meat, eggs, and fish, are the main sources of TMAO. Excessively consuming such diets not only directly affects energy metabolism in liver, but also increases the concentration of TMAO in plasma, which promotes the development of MAFLD by affecting bile acid metabolism, unfolded protein response, and oxidative stress. In this review, we focused on the relationship between TMAO and MAFLD and summarized intervention strategies for reducing circulating TMAO concentration, aiming at providing new targets for the prevention and treatment of MAFLD.
Insights
Trimethylamine-N-oxide (TMAO), a gut microbe metabolite, is linked to metabolic dysfunction-associated fatty liver disease (MAFLD). Dietary changes targeting TMAO may offer new strategies for MAFLD prevention and treatment.
Area of Science:
- Metabolomics
- Gastroenterology
- Hepatology
Background:
- Trimethylamine-N-oxide (TMAO) is a metabolite produced by gut microbiota.
- TMAO is increasingly recognized as a potential risk factor for metabolic dysfunction-associated fatty liver disease (MAFLD).
Purpose of the Study:
- To review the relationship between TMAO and MAFLD.
- To summarize strategies for reducing TMAO levels for MAFLD prevention and treatment.
Main Methods:
- Literature review focusing on TMAO metabolism and its role in MAFLD pathogenesis.
- Analysis of dietary influences on TMAO production and circulation.
- Examination of TMAO's impact on liver metabolic pathways.
Main Results:
- High-nutrient diets rich in TMA precursors (red meat, eggs, fish) increase plasma TMAO.
- Elevated TMAO promotes MAFLD development by affecting bile acid metabolism, unfolded protein response, and oxidative stress.
- TMAO is synthesized in the liver from gut-derived trimethylamine (TMA) via hepatic flavin monooxygenases (FMOs).
Conclusions:
- Circulating TMAO levels are associated with MAFLD development.
- Intervention strategies aimed at reducing TMAO warrant further investigation for MAFLD management.
- Targeting gut microbiota and dietary precursors may be beneficial for preventing and treating MAFLD.
More Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...


